PharmaceuticalsMay 28, 2024
Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes
Rachel Fairbank is a freelance science writer.
Ozempic Cuts Risk of Kidney Disease Death in People with Diabetes
Semaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for people with type 2 diabetes